Drug Information

Drug General Information
Drug ID
D01HFL
Former ID
DNC008783
Drug Name
2,4,4-triphenylimidazoline
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529977]
Structure
Download
2D MOL

3D MOL
Formula
C21H18N2
Canonical SMILES
C1C(NC(=N1)C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4
InChI
1S/C21H18N2/c1-4-10-17(11-5-1)20-22-16-21(23-20,18-12-6-2-7-13-18)19-14-8-3-9-15-19/h1-15H,16H2,(H,22,23)
InChIKey
KXSXOHNHKQJMNF-UHFFFAOYSA-N
PubChem Compound ID
22054806
Target and Pathway
Target(s) Neuropeptide Y receptor 5 Target Info Inhibitor [529977]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 529977Bioorg Med Chem Lett. 2009 Mar 15;19(6):1670-4. Epub 2009 Feb 4.Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists.
Ref 529977Bioorg Med Chem Lett. 2009 Mar 15;19(6):1670-4. Epub 2009 Feb 4.Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.